NSE · SHUKRAPHAR

Shukra Pharmaceuticals Limited

Sector: Healthcare · ISIN: INE551C01044

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#1,072

of 5,004 stocks

🏆 New peak

▲ 491W

Peak #1,072 · 01 Oct 2026

Shukra Pharmaceuticals Limited is a smallcap company in the Healthcare space and carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and generates a high return on equity. Ownership as of Aug 2026.

Market Cap

2,718.79 Cr

P/E Ratio

124.18

P/B Ratio

30.29

ROE

24.55%

ROCE

31.67%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	23.52 Cr	6.32 Cr	39.13 Cr	5.88 Cr
Net Profit	12.96 Cr	-2.02 Cr	20.36 Cr	2.38 Cr
EPS	0.30	0.04	0.47	0.05
Operating Profit	18.60 Cr	33.99 L	27.11 Cr	48.35 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

51.15%

Public

48.85%

PUBLIC BREAKDOWN

FII

0.00%

DII

0.11%

Individuals

47.64%

As of 03 Aug 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs